RTTNews) - Gilead Sciences Inc. (GILD) announced that phase 1 study data showed two different formulations of once-yearly lenacapavir, administered via intramuscular injection, achieved and maintained plasma concentrations exceeding those associated with HIV prevention efficacy...
4336 Plainfield Ave ne Grand Rapids Michigan 49525
16162083711
fitlifehere@gmail.com
Copyright © 2023 fitlife. All Rights Reserved